Press Releases

Tendonitis Treatment Market Size to Worth Around USD zz Bn by 2030

Share This Article

The global Tendonitis Treatment market is expected to grow at a CAGR of around 8.8% over the forecast period 2021 to 2030 and expected to reach the market value of around US$ 335.4 billion by 2030.

Download Exclusive Sample of Report@  https://www.visionresearchreports.com/report/sample/38476

Growth Factors

Individuals are proactively participating in sporting or physical activities and the probability of sports-related injuries occurring is rising, thereby contributing to the market development and growth. The growing global geriatric population is susceptible to tendonitis or could be suffering from bone disorders, osteoporosis, rheumatoid arthritis, diabetes, and osteoarthritis. Constant innovation of technologies and therapies in treating tendonitis is contributing to the growth. Supportive government initiatives and significant investments and collaborations amongst key players to expand product offerings are boosting the market growth. growing reliance on technologies in mapping various factors concerning sports, such as performance assessment, training modules, and sports injuries tracking and monitoring. The shift from proactive to preventive therapies is proving to be beneficial in improving the health status of sports players to prevent injuries. Sporting and physical activities are witnessing significant participation, and this paves way for possibilities of incurring sports injuries. 

Report Highlights

the therapy treatment segment dominated the market for tendonitis treatment and accounted for the largest revenue share of 83.4%. It is attributed to the increasing preference for non-invasive therapies over surgical procedures for tendonitis treatment by target patients. Among the therapy segment, physical therapy accounted for the largest market share on the account of being the first line of treatment.

the Achilles tendonitis segment dominated the market owing to the rising occurrence in sports players and athletes. As per the NCBI article titled ‘Biomedical Risk Factors of Achilles Tendinopathy in Physically Active People’ stated, the cumulative lifetime incidence of injury for Achilles Tendonitis is estimated to be approximately 24.0% in athletes in 2021. In addition, it has been reported that elite adolescent athletes have a frequency of 1.0% – 2.0% for Achilles tendinopathy, whereas the frequency of injury was reported to be 9.0% in recreational athletes.

Asia Pacific dominated the market for tendonitis treatment and accounted for the largest revenue share of 69.7% in 2020 owing to the growing number of tendonitis surgeries performed in the region and rising disposable income. Increasing penetration of local manufacturers of medical devices and growing target population has resulted in significant growth opportunities for the tendonitis treatment market in the region.

Key Players

  • Merck and Co., Inc.
  • AstraZeneca
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Abbott
  • Pfizer
  • Bayer AG
  • GlaxoSmithKline PLC
  • Almatica Pharma, Inc.
  • Teva Pharmaceuticals Industries
Report Coverage Details
Market Size US$ 335.4 billion by 2030
Growth Rate CAGR of 8.8% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Treatment, Condition
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Merck and Co., Inc.; Bayer AG; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Abbott; Pfizer; GlaxoSmithKline PLC; Almatica Pharma, Inc.; Teva Pharmaceuticals Industries

Market Segmentation

  • Treatment
    • Therapy
      • Hot and Cold Therapy
      • Physical Therapy
      • Shockwave Therapy
    • Surgery
  • Condition
    • Tennis Elbow
    • Golfer’s Elbow
    • Pitcher’s Elbow
    • Jumper’s Knee
    • Swimmer’s Shoulder
    • Achilles Tendonitis
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Spain
      • Italy
      • France
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • Singapore
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38476

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Tendonitis Treatment Market, By Treatment

7.1.  Tendonitis Treatment Market, by Treatment, 2021-2030

7.1.1.    Therapy

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Surgery

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Tendonitis Treatment Market, By Condition

8.1.  Tendonitis Treatment Market, by Condition, 2021-2030

8.1.1.    Tennis Elbow

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Golfer’s Elbow

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Pitcher’s Elbow

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Jumper’s Knee

8.1.4.1.        Market Revenue and Forecast (2017-2030)

8.1.5.    Swimmer’s Shoulder

8.1.5.1.        Market Revenue and Forecast (2017-2030)

8.1.6.    Achilles Tendonitis

8.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Tendonitis Treatment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Treatment (2017-2030)

9.1.2.    Market Revenue and Forecast, by Condition (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Treatment (2017-2030)

9.2.2.    Market Revenue and Forecast, by Condition (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Treatment (2017-2030)

9.3.2.    Market Revenue and Forecast, by Condition (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Treatment (2017-2030)

9.4.2.    Market Revenue and Forecast, by Condition (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Treatment (2017-2030)

9.5.2.    Market Revenue and Forecast, by Condition (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Condition (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Treatment (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Condition (2017-2030)

Chapter 10.  Company Profiles

10.1.              Merck and Co., Inc.

10.1.1.  Company Overview

10.1.2.  Treatment Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              AstraZeneca

10.2.1.  Company Overview

10.2.2.  Treatment Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Boehringer Ingelheim Pharmaceuticals, Inc.

10.3.1.  Company Overview

10.3.2.  Treatment Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Abbott

10.4.1.  Company Overview

10.4.2.  Treatment Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Pfizer

10.5.1.  Company Overview

10.5.2.  Treatment Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Bayer AG

10.6.1.  Company Overview

10.6.2.  Treatment Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              GlaxoSmithKline PLC

10.7.1.  Company Overview

10.7.2.  Treatment Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Almatica Pharma, Inc.

10.8.1.  Company Overview

10.8.2.  Treatment Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Teva Pharmaceuticals Industries

10.9.1.  Company Overview

10.9.2.  Treatment Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38476

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button